APA (7th ed.) Citation

Barreiro‐de Acosta, M., Zabana, Y., Nieto‐García, L., Poncela, M., Aguas, M., Martínez‐Cuevas, C., . . . Baston‐Rey, I. (2026). Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry. Alimentary Pharmacology & Therapeutics, 1. https://doi.org/10.1111/apt.70783

Chicago Style (17th ed.) Citation

Barreiro‐de Acosta, Manuel, et al. "Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry." Alimentary Pharmacology & Therapeutics 2026: 1. https://doi.org/10.1111/apt.70783.

MLA (9th ed.) Citation

Barreiro‐de Acosta, Manuel, et al. "Real‐World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry." Alimentary Pharmacology & Therapeutics, 2026, p. 1, https://doi.org/10.1111/apt.70783.